Lynk Pharmaceuticals
凌科药业
Lynk Pharmaceuticals
Biotech/Healthcare
Linker Pharmaceuticals is an innovative small-molecule drug developer focused on small-molecule therapies for oncology and autoimmune diseases, as well as the development of a new-drug screening platform. Its business includes early-stage drug research, drug sales, patent licensing and transfers…
Latest round: Series C Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.